Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: The Finnish Diabetes Prevention Study

[1]  Mark Woodward,et al.  Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. , 2008, Journal of clinical epidemiology.

[2]  Philippe Pibarot,et al.  Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[3]  J. Hoeks,et al.  Mitochondrial uncoupling protein 3 and its role in cardiac- and skeletal muscle metabolism , 2008, Physiology & Behavior.

[4]  D. Grobbee,et al.  Variations in the uncoupling protein-3 gene are associated with specific obesity phenotypes. , 2008, European journal of endocrinology.

[5]  M. Marre,et al.  The Common −866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men , 2008, Diabetes.

[6]  K. Kotani,et al.  The common -55 C/T polymorphism in the promoter region of the uncoupling protein 3 gene reduces prevalence of obesity and elevates serum high-density lipoprotein cholesterol levels in the general Japanese population. , 2008, Metabolism: clinical and experimental.

[7]  Lisa J. Martin,et al.  Meta‐Analysis of Genome‐wide Linkage Studies in BMI and Obesity , 2007, Obesity.

[8]  D. D. de Luis,et al.  Lack of Association of –55CT Polymorphism of UCP3 Gene with Fat Distribution in Obese Patients , 2007, Annals of Nutrition and Metabolism.

[9]  S. Choi,et al.  Association of UCP2 and UCP3 gene polymorphisms with serum high-density lipoprotein cholesterol among Korean women. , 2007, Metabolism: clinical and experimental.

[10]  M. Harper,et al.  Uncoupling protein‐3: clues in an ongoing mitochondrial mystery , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  C. Chan,et al.  Regulation of insulin secretion by uncoupling protein. , 2006, Biochemical Society transactions.

[12]  H. Shin,et al.  The effects of uncoupling protein 3 haplotypes on obesity phenotypes and very low-energy diet-induced changes among overweight Korean female subjects. , 2006, Metabolism: clinical and experimental.

[13]  S. Humphries,et al.  Variation in the UCP2-UCP3 Gene Cluster Predicts the Development of Type 2 Diabetes in Healthy Middle-Aged Men , 2006, Diabetes.

[14]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[15]  C. Bogardus,et al.  Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians , 2005, Diabetologia.

[16]  J. Long,et al.  Linkage and association analyses of the UCP3 gene with obesity phenotypes in Caucasian families. , 2005, Physiological genomics.

[17]  B. Paulweber,et al.  Associations of the UCP2 Gene Locus With Asymptomatic Carotid Atherosclerosis in Middle-Aged Women , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[18]  A. Quattrone,et al.  The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. , 2005, The Journal of clinical endocrinology and metabolism.

[19]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[20]  C. Bellanné-Chantelot,et al.  A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes. , 2004, Molecular genetics and metabolism.

[21]  G. Sesti,et al.  The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. , 2004, Diabetes.

[22]  R. Hamman,et al.  Genetic variation in uncoupling protein 3 is associated with dietary intake and body composition in females. , 2004, Metabolism: clinical and experimental.

[23]  D. Tregouet,et al.  A new algorithm for haplotype‐based association analysis: the Stochastic‐EM algorithm , 2004, Annals of human genetics.

[24]  S. Humphries,et al.  Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. , 2004, European heart journal.

[25]  K. Ueda,et al.  Uncoupling Protein 2 Promoter Polymorphism −866G/A Affects Its Expression in β-Cells and Modulates Clinical Profiles of Japanese Type 2 Diabetic Patients , 2004 .

[26]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Marchetti,et al.  A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. , 2003, Diabetes.

[28]  J. Staessen,et al.  Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio , 2003, Journal of Molecular Medicine.

[29]  C. Bouchard,et al.  Lack of association between the uncoupling protein-2 Ala55Val gene polymorphism and phenotypic features of the Metabolic Syndrome. , 2002, Biochimica et biophysica acta.

[30]  H. Esterbauer,et al.  A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. , 2002, Diabetes.

[31]  P. Schrauwen,et al.  UCP2 and UCP3 in muscle controlling body metabolism. , 2002, The Journal of experimental biology.

[32]  F. López‐Soriano,et al.  The role of uncoupling proteins in pathophysiological states. , 2002, Biochemical and biophysical research communications.

[33]  Y. Chagnon,et al.  Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding , 2001, European Journal of Clinical Nutrition.

[34]  O. Pedersen,et al.  Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes , 2001, Diabetologia.

[35]  S. O’Rahilly.  Uncoupling protein 2: Adiposity angel and diabetes devil? , 2001, Nature Medicine.

[36]  Young-Bum Kim,et al.  Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes , 2001, Cell.

[37]  B. Paulweber,et al.  A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans , 2001, Nature Genetics.

[38]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[39]  S. O’Rahilly,et al.  Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population , 2001, International Journal of Obesity.

[40]  T. Hansen,et al.  A prevalent polymorphism in the promoter of the UCP3 gene and its relationship to body mass index and long term body weight change in the Danish population. , 2001, The Journal of clinical endocrinology and metabolism.

[41]  B. Miroux,et al.  Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production , 2000, Nature Genetics.

[42]  Alan E. Jackson,et al.  Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin , 2000, Diabetologia.

[43]  A. de Leiva,et al.  Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test , 2000, Diabetologia.

[44]  P. Froguel,et al.  An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort , 2000, Diabetologia.

[45]  T. Valle,et al.  The Finnish Diabetes Prevention Study , 2000, British Journal of Nutrition.

[46]  K. Clément,et al.  A genetic variation in the 5 ′ flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity , 2000, Diabetologia.

[47]  T. Valle,et al.  Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland Study design and 1-year interim report on the feasibility of the lifestyle intervention programme , 1999, Diabetologia.

[48]  M. McCarthy,et al.  An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes , 1999, Diabetologia.

[49]  R. A. Norman,et al.  Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. , 1998, Human molecular genetics.

[50]  M. Kasuga,et al.  Molecular screening of uncoupling protein 2 gene in patients with noninsulin-dependent diabetes mellitus or obesity. , 1998, The Journal of clinical endocrinology and metabolism.

[51]  B. Lowell,et al.  The Human Uncoupling Protein-3 Gene , 1997, The Journal of Biological Chemistry.

[52]  Christophe Fleury,et al.  Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia , 1997, Nature Genetics.

[53]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[54]  P. Kern,et al.  Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. , 2004, American journal of physiology. Endocrinology and metabolism.

[55]  S. Le Fur,et al.  The common -866 G/A polymorphism in the promoter of uncoupling protein 2 is associated with increased carbohydrate and decreased lipid oxidation in juvenile obesity. , 2004, Diabetes.

[56]  B. Lowell,et al.  Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. , 2001, Cell.

[57]  E. Ravussin,et al.  Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. , 1999, Diabetes.

[58]  E. Ravussin,et al.  A novel polymorphism in the proximal UCP3 promoter region: effect on skeletal muscle UCP3 mRNA expression and obesity in male non-diabetic Pima Indians , 1999, International Journal of Obesity.

[59]  E. Ropelle,et al.  The FASEB Journal • Research Communication Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion , 2022 .